September 10, 2015

Express Scripts on Thursday announced the retirement of George Paz as CEO, effective after the company's annual stockholders meeting in May 2016. Company President Tim Wentworth will succeed Paz.

August 14, 2015
Pfizer on Friday announced that it would be selling four of its Canadian pharmaceutical products to alleviate concerns from Canada’s Competition Bureau and pave the way for its acquisition of Hospira. 
July 29, 2015

Patients were unable to follow approprate treatment protocols for an OTC Lipitor, so Pfizer decided to discountinue its switch application. 

February 9, 2015

Onco360 on Monday announced that it has been selected by Pfizer as a limited-distribution pharmacy network participant for Ibrance (palbociclib), Pfizer’s recently approved product for certain breast cancers.

January 26, 2015

NJOY announced the appointment of Paul Sturman as its new CEO and president. 


January 22, 2015

Family Dollar Stores on Thursday announced that, based on a preliminary count of the votes cast at the company’s special meeting of stockholders held today, Family Dollar stockholders voted to approve the proposed merger with Dollar Tree.


December 4, 2014

Diplomat Pharmacy announced Wednesday that it has been selected to Pfizer's limited-distribution panel for Xalkori, Bosulif, Inlyta and Sutent.

November 10, 2014

Dollar Tree on Friday announced that it has certified substantial compliance with the request for additional information issued by the Federal Trade Commission regarding its proposed acquisition of Family Dollar Stores.


October 24, 2014

Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.

September 25, 2014

Pfizer announced on Thursday that it has completed its acquisition of the pharmaceutical development company, InnoPharma, following receipt of U.S. regulatory approval from all government authorities required by the agreement and other closing conditions.

July 30, 2014

Pfizer on Wednesday announced that it has entered into a definitive agreement to acquire Baxter International’s portfolio of marketed vaccines for $635 million.

July 1, 2014

L'Oréal USA announced that it has reached an agreement with the Federal Trade Commission, ending an inquiry regarding certain advertising claims that were discontinued some time ago.

May 19, 2014

Pfizer on Sunday made a final offer valued at $118 billion for AstraZeneca. AstraZeneca, in turn, rejected the bid Monday morning.

May 13, 2014

Pfizer testified before British Parliament Tuesday regarding its proposed offer to acquire AstraZeneca, the New York Times reported.

May 2, 2014

AstraZeneca rejected Pfizer's $106 billion bid for the company Friday morning.

May 2, 2014

Pfizer early Friday morning upped the ante in its bid for AstraZeneca, which is now valued at $106 billion.

April 28, 2014

U.S. pharmaceutical firm Pfizer this morning confirmed discussions with AstraZeneca regarding a possible merger. If the transaction goes through, it's expected that the two companies will combine under a new U.K-incorporated holding company.

April 17, 2014

Teva Pharmaceutical announced that its U.S. subsidiary has entered into a settlement with Pfizer related to Teva's generic version of Celebrex (celecoxib) 50-, 100-, 200- and 400-mg capsules in the United States.

April 11, 2014

Ian Read, chairman and CEO of Pfizer, was elected chairman of the Pharmaceutical Research and Manufacturers of America at the trade association’s annual meeting.

March 18, 2014

Pfizer has sued Torrent Pharmaceuticals in an effort to protect its erectile-dysfunction drug Viagra (sildenafil citrate) from generic competition, according to a Bloomberg News report published Tuesday.

March 3, 2014

Pfizer is recruiting for a 1,200-patient actual use study to measure whether or not patients can appropriately self-select treating high cholesterol with the statin Lipitor, the Wall Street Journal reported on Sunday.

January 24, 2014

Armada Health Care on Thursday added featured speaker Myrtle Potter to its card at the 2014 Specialty Pharmacy Summit and Expo to be held in Las Vegas May 5 to 9.

January 21, 2014

Greenstone, a U.S.-based generic pharmaceutical subsidiary of Pfizer, on Tuesday announced the introduction of Sirolimus to its generic pharmaceutical product line.

January 14, 2014

Three drug makers are looking into buying Pfizer's branded-generics drug business, according to published reports.